Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system

D Bazile1, C Prud'homme, M T Bassoullet

  • 1Pharmaceutical Sciences Department, Institut de Biopharmacie, Antony, France.

Journal of Pharmaceutical Sciences
|April 1, 1995
PubMed
Summary

Methoxy poly(ethylene glycol)poly(d,l-lactic acid) (Me.PEG-PLA) nanoparticles exhibit prolonged circulation times in vivo. This enhanced performance is attributed to their ability to evade the mononuclear phagocyte system, a key factor in nanoparticle longevity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Encapsulation of oligonucleotides in stealth Me.PEG-PLA50 nanoparticles by complexation with structured oligopeptides.

Drug delivery·2016
Same author

A method to Quantify the Affinity of Cabazitaxel for PLA-PEG Nanoparticles and Investigate the Influence of the Nano-Assembly Structure on the Drug/Particle Association.

Pharmaceutical research·2015
Same author

Late recurrence or secondary location? Towards a better understanding of the physiopathology of inverted papilloma.

European annals of otorhinolaryngology, head and neck diseases·2013
Same author

A 'cyanoacrylate case' for developing fingerprints in cars.

Science & justice : journal of the Forensic Science Society·2000
Same author

Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.

Journal of drug targeting·1999
Same author

Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system.

Biomaterials·1997

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Pharmacokinetics

Background:

  • Poly(d,l-lactic acid) (PLA) nanoparticles are widely investigated for drug delivery.
  • PLA nanoparticles are rapidly cleared from circulation by the mononuclear phagocyte system (MPS).
  • Surface modification is crucial for prolonging nanoparticle circulation time.

Purpose of the Study:

  • To synthesize and characterize Me.PEG-PLA nanoparticles.
  • To evaluate the in vitro cellular uptake and in vivo pharmacokinetics of Me.PEG-PLA nanoparticles.
  • To elucidate the mechanism behind MPS evasion.

Main Methods:

  • Precipitation-solvent diffusion method for nanoparticle preparation.
  • [14C]PLA labeling for tracking.
  • In vitro studies using THP-1 monocytes.

Related Experiment Videos

  • In vivo pharmacokinetic studies in rats.

    • Main Results:

    • Me.PEG-PLA nanoparticles showed slower uptake by THP-1 monocytes compared to F68-coated PLA nanoparticles.
    • PEG chain length influenced nanoparticle capture by monocytes.
    • Intravenous administration of Me.PEG-PLA nanoparticles resulted in an 180-fold increase in plasma half-life compared to F68-coated PLA nanoparticles.
    • MPS evasion was correlated with PEG surface density.

    Conclusions:

    • Me.PEG-PLA nanoparticles demonstrate significantly improved pharmacokinetic profiles.
    • Surface PEG density is a critical determinant for avoiding MPS capture.
    • These findings highlight the potential of Me.PEG-PLA nanoparticles for enhanced drug delivery applications.